RecruitingPhase 4ACTRN12611000829910

Comparison of the safety and efficacy of a morphine-alfentanil mixture versus morphine alone for the management of severe pain in the Emergency Department

In emergency department patients at Lyell McEwin Hospital is a morphine-alfentanil mixture more effective than morphine alone in reducing pain scores


Sponsor

Dr. Adrianne Boonstra

Enrollment

330 participants

Start Date

May 30, 2011

Study Type

Interventional

Conditions

Summary

This study will compare the safety and efficacy of morphine-alfentanil mixture with morphine alone for the treatment of severe pain in the emergency department at the Lyell McEwin Hospital. Alfentanil is a short acting opiate with rapid onset, where morphine is a longer acting opiate which is slower in its onset of action. It has previously been shown, in post-surgical patients, that a mixture of alfentanil and morphine can safely reduce the time to comfort when compared with morphine alone. We hypothesize that within the emergency department, the alfentanil-morphine mixture will safely reduce the time to effective analgesia.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 70 Yearss

Plain Language Summary

Simplified for easier understanding

This study is testing whether adding a fast-acting painkiller (alfentanil) to the standard slower-acting painkiller (morphine) can relieve severe pain more quickly in the emergency department. Alfentanil kicks in within minutes while morphine takes longer to work. Combining them may give patients faster relief without extra risk. Participants are randomly assigned to receive either the combination or morphine alone. You may be eligible if: - You are between 18 and 70 years old - You have severe pain (score of 7 or higher out of 10) - You weigh more than 50 kg - You can communicate clearly in English You may NOT be eligible if: - You are allergic to alfentanil, fentanyl, or morphine - You have severe heart or breathing disease - You regularly use opioids or have a history of opioid dependence - You take monoamine oxidase inhibitor (MAOI) medications - You have significant cognitive impairment - You have kidney or liver problems - You are pregnant or breastfeeding Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Patients with acute pain with pain scores greater than or equal to 7 will be administered analgesia according to a standard protocol, either receiving the trial medication (a mixture of morphine and a

Patients with acute pain with pain scores greater than or equal to 7 will be administered analgesia according to a standard protocol, either receiving the trial medication (a mixture of morphine and alfentanil) or the comparator, morphine alone. The morphine-alfentanil mixture will be in premixed syringes containing 50mcg of alfentanil and 0.75 mg of morphine per millilitre. Patients will be administered bolus doses of one to four millilitres at no less than three minutely intervals until their pain is adequately controlled, provided they do not experience adverse effects or need to be withdrawn from the trial.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000829910